Optimization of a liquid chromatographic separation for the simultaneous determination of four anthracyclines and their respective 13-S-dihydro metabolites.
The optimization of a liquid chromatographic separation of four anthracyclines (doxorubicin, epirubicin, daunorubicin and idarubicin) and their respective 13-S-dihydro metabolites (doxorubicinol, epirubicinol, daunorubicinol and idarubicinol) is described. Inclusion of epidaunorubicin in the assay allows internal standardization. Potential chromatographic interference of aglycones (doxorubicinone, daunorubicinone, idarubicinone, doxorubicinolone, daunorubicinolone and idarubicinolone) was investigated and tackled. The analyses were performed on a C18 RP column and gradient elutions were performed with a mixture of 0.1% formic acid in water and 0.1% formic acid in ACN. The analytes were measured by fluorescence detection with an excitation wavelength of 480 nm and emission wavelength of 555 nm, respectively. The separation will potentially allow a broad field of applications, ranging from therapeutic drug monitoring and kinetic studies in cancer patients to monitoring hospital personnel and effluents.
Maudens
Kristof E
KE
Laboratory of Toxicology, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
Stove
Christophe P
CP
Lambert
Willy E
WE
D018943:Anthracyclines / Q000737:chemistry* / Q000302:isolation & purification* / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid / Q000295:instrumentation* / Q000379:methods*; D006859:Hydrogen / Q000737:chemistry*; D015394:Molecular Structure; D013997:Time Factors
D018943:Anthracyclines; D006859:Hydrogen